Oncopeptides AB (publ)
ONPPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $179 | $173 | $345 | $362 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $11 | $2 | $1 | $12 |
| Inventory | $4 | $2 | $0 | $0 |
| Other Curr. Assets | $23 | $25 | $18 | $36 |
| Total Curr. Assets | $217 | $203 | $364 | $412 |
| Property Plant & Equip (Net) | $27 | $35 | $20 | $25 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $1 |
| Long-Term Investments | $0 | $0 | $1 | $1 |
| Tax Assets | $0 | $0 | $0 | -$1 |
| Other NC Assets | $0 | $1 | $0 | -$26 |
| Total NC Assets | $27 | $35 | $21 | $27 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $244 | $238 | $385 | $439 |
| Liabilities | – | – | – | – |
| Payables | $18 | $15 | $28 | $36 |
| Short-Term Debt | $0 | $0 | $6 | $11 |
| Tax Payable | $0 | $1 | $7 | $7 |
| Deferred Revenue | $0 | $0 | $28 | $129 |
| Other Curr. Liab. | $33 | $29 | $17 | $43 |
| Total Curr. Liab. | $51 | $45 | $86 | $225 |
| LT Debt | $134 | $126 | $4 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $11 | $2 | $0 |
| Total NC Liab. | $139 | $137 | $5 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13 | $20 | $10 | $14 |
| Total Liabilities | $190 | $182 | $91 | $229 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $11 | $10 | $8 |
| Retained Earnings | $0 | -$5,366 | -$5,116 | -$4,778 |
| AOCI | $0 | -$2 | -$2 | -$1 |
| Other Equity | $54 | $5,414 | $5,403 | $4,982 |
| Total Equity | $54 | $57 | $294 | $211 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $244 | $238 | $385 | $439 |
| Net Debt | -$44 | -$47 | -$335 | -$348 |